Global Placental Stem Cell Collection and Storage Market

Global Placental Stem Cell Collection and Storage Market Size, Status and Forecast 2020-2026

Placental stem cells are cells sourced from the placenta, which is collected after delivery of full-term healthy babies. Placental Stem Cell are easily accessible and do not have the limitations and ethical concerns associated with the potential clinical use of embryonic and induced pluripotent stem cells.

Type

Placental Subtopotent Stem Cells

Placental Hematopoietic Stem Cells

Placental Mesenchymal Stem Cells (MSC)

Placental Maternal Pluripotent Stem Cells


% P- u$ y$ f) E# O( A

The major Placental Stem Cell Collection and Storage player in the market

Americord

Pluristem TherapeuticsPSTI

China Cord Blood Corporation

Celularity

LifebankUSA

Americord Registry

ReeLabs

Ocata Therapeutics

Mesoblast Limited

Caladrius Biosciences

CBR Systems, Inc.

Cordlife

Cryo-Cell

Stemcyte

Viacord

Smart Cells International Ltd.

Cryoviva India

Cells4Life

H&B Group

Cryobank


' [' z: y1 j4 v

Stem cell size grew at a compound rate of 30%. The global market for stem cells is expected to reach $400 billion by 2020 from US$ 385 million in 2019. The market size of Stem cell will reach US$563 billion in 2026, with a CAGR of 34.8% from 2020 to 2026.

Figure 1.   Global Stem cell Market Size (Value), (US$ Billion), 2015 VS 2020 VS 2026

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

North America and Western Europe are the two largest stem cell markets, with market shares of 44% and 38%, respectively. The Asia-pacific region is the third largest stem cell market with a 17 percent market share. The rest of the world accounts for only about 1 percent of stem cells.

Figure 2.  Global Placental Stem Cell Collection and Storage Market Share by Region in 2019

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

The umbilical Placental Stem Cell Collection and Storage penetration rate in China is about 1%. China umbilical cord blood bank group (CO), a representative company, currently carries out umbilical Placental Stem Cell Collection and Storage services in Beijing, Guangdong and Zhejiang provinces. The annual report disclosed by CO shows that the three provinces had a combined total of 1.782,400, 1.9704 million and 1.8734 million in 12 to 14 years The contracted customers were 53,900, 72,200 and 64,600, respectively, from which it was estimated that Placental Stem Cell Collection and Storage infiltration occurred from 2012 to 2014The rates were 3.03%, 3.67% and 3.45%, respectively The rate of umbilical cord blood storage can reach more than 20%.

At present, the most fierce competition in the stem cell industry is that of the stem cell industry. In the upstream industry, with the advancement of the development of stem cell drugs in the future, the competition focus of the whole stem cell industry will shift to the middle and downstream, especially the innovative stem cell drugs.

Table1: Stem Cell Industry Chain

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

The middle and downstream applications of stem cells are the core of the industrial chain. Medical-grade applications refer to medical applications, such as the treatment of many diseases; Consumer applications are mainly in the beauty field, such as anti-aging products, stem cell technology in the consumer products. The stem cell storage market accounts for less than 20% of the total market size of the stem cell industry, and is in the middle and lower reaches. The application of products is the main field of enterprise competition and the main growth point.

Table2: Global 3 ~4 w: z+ I7 G! ?: T) ]# v
Leading Stem Cell Products

Source: Secondary Sources, Expert Interviews and QYResearch, 2020


4 e5 [* @, H4 Y& O9 p

Figure 3.   Global Aesthetic Medical Revenue 2015-2026 (US$ Billion)

1 A* `4 C6 J" U" A; I5 Q; ?4 e

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Figure 4.   Global Stem Cell Products in Aesthetic Medical Market Size 2013-2015


' x5 L. j7 i7 `3 b8 V7 `1 H" O1 L

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Placental Stem Cell Collection and Storage market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of coronavirus COVID-19 on the Placental Stem Cell Collection and Storage industry.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Placental Stem Cell Collection and Storage market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Placental Stem Cell Collection and Storage market in terms of revenue.

Players, stakeholders, and other participants in the global Placental Stem Cell Collection and Storage market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Placental Stem Cell Collection and Storage market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Placental Stem Cell Collection and Storage market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Placental Stem Cell Collection and Storage market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Placental Stem Cell Collection and Storage market.

The following players are covered in this report:

Americord

Cryobank

China Cord Blood Corporation

Celularity

LifebankUSA

Americord Registry

ReeLabs

Pluristem Therapeutics Inc (PSTI)

Ocata Therapeutics

Mesoblast Limited

Caladrius Biosciences

CBR Systems, Inc.

Cordlife

Cryo-Cell

Stemcyte

Viacord

Smart Cells International

Cryoviva India

Cells4Life

H&B Group

Placental Stem Cell Collection and Storage Breakdown Data by Type

Placental Subtopotent Stem Cells

Placental Hematopoietic Stem Cells

Placental Mesenchymal Stem Cells (MSC)

Placental Maternal Pluripotent Stem Cells

Placental Stem Cell Collection and Storage Breakdown Data by Application

Cell Therapy

Beauty Products

Other

for more information

please go  https://www.qyresearch.com/index ... -and-storage-market

and you can go https://www.qyresearch.comto know more and more

if you need any help you can contact

qifeifei@qyresearch.com / telephone number :18910840196

00861082945717

QY Research support best market reports for you.

Share |
Share